当前位置: 首页 > 期刊 > 《第四军医大学学报》 > 2005年第17期
编号:10949429
急性肾衰患者血浆中DD, tPA和PAI的改变及临床意义
http://www.100md.com 《第四军医大学学报》 2005年第17期
肾功能衰竭,,肾功能衰竭,急性;D二聚体;组织型纤溶酶原激活物;纤溶酶原灭活剂,急性肾衰患者血浆中DD,tPA和PAI的改变及临床意义,0引言,1对象和方法,2结果,3讨论,【参考文献】
     Clinical significance of changes of DD, tPA and PAI in acute renal failure patients

    TENG Yan, XUE WuJun, ZHANG Yan, JIANG HongLi, XIANG HeLi

    1Nephropathy Center, First Hospital, Xian Jiaotong University, 2Department of Blood Typing, Blood Center of Shaanxi Province, Xian 710061, China

    【Abstract】 AIM: To investigate the clinical significance and the changes of coagulation and fibrinolysis function in acute renal failure patients. METHODS: The level of plasma DD and the activity of tissuetype plasminogen activator (tPA) and plasminogen activator inhibitor (PAI) were determined in 37 acute renal failure (ARF) patients while those of the healthy people were used as control. RESULTS: ① The plasma DD level and the PAI activity in ARF patients were obviously higher and the tPA activity was lower than those in control group(P<0.05). ②Significant difference of the above changes was also found in postrenal failure groups, prerenal and renal failure groups and between simple ARF patients and renal failure patients combined with multiple organ dysfunction syndrome (MODS)(P<0.05). CONCLUSION: There was a disorder of coagulation and fibrinolysis system in ARF patients. ARF, caused by ischemic and toxicosis or combined with MODS, has the greatest effect on the changes on coagulation system. Plasma DD, tPA and PAI can be used clinically as effective and sensitive markers reflecting the abnormal changes of coagulation and fibrinolysis system. ......

您现在查看是摘要页,全文长 9201 字符